Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol reconsolidation blockade for PTSD
ACTRN12624001480572Phase 3Not yet recruiting
- Sponsor
- University of the Sunshine Coast
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of propranolol in post-traumatic stress disorder (PTSD), sponsored by University of the Sunshine Coast. Primary endpoint: Change in PTSD symptomatology. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on ACTRN12624001480572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001480572.